Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Nobelpharma clinical trials
Part of Hisanaga & Co., Ltd., which holds 73.9% as of 2025-12-31. Source
The registry lists 34 studies whose lead sponsor is Nobelpharma. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 17, 2025.
Registry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Nobelpharma.
- Nobelpharma34 studiesSame company
Something wrong?
Studies
Recruiting first, then most recently updated. Showing 34 of 34.
- Pharmacokinetics of NPC-01 After Single Oral Administration in Healthy Female VolunteersCompletedNCT01246791Phase 3
- A Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus InfectionCompletedNCT04225923Phase 2
- Efficacy and Safety, Long-Term Study of NPC-01 to Treat Dysmenorrhea Associated With EndometriosisCompletedNCT00902746Phase 3
- Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Primary DysmenorrheaCompletedNCT00746096Phase 3
- Pharmacodynamics of NPC-01/IKH-01; Effect of NPC-01/IKH-01 on Sexual Hormone Concentrations in Healthy Female VolunteersCompletedNCT01253824Phase 3
- Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan.CompletedNCT00212355Phase 3
- Efficacy and Safety Study of NPC-01 to Treat DysmenorrheaCompletedNCT01129102Phase 3
- Clinical Study of NPC-12Y Gel in Patients With Skin Lesions Associated With TSCCompletedNCT05495425Phase 3
- A Phase II/III Study of SargramostimCompletedNCT04642950Phase 2/3
- NPC-06 to Pain Associated With Acute Herpes ZosterCompletedNCT05480553Phase 3
- A Long-term Study of NPC-12G Gel in Neurofibromatosis Type ITerminatedNCT04461886Phase 3
- Efficacy Confirmation Study of NPC-09CompletedNCT04671472Phase 3
- An Additional Study of NPC-22 in Healthy Adult MalesCompletedNCT04503863Phase 1
- NPC-06 to Acute Pain in Herpes ZosterTerminatedNCT04139330Phase 2
- Phase II Clinical Trial of NPC-06 in Patients With Neuropathic Pain in CancerTerminatedNCT03773055Phase 2
- A Study of NPC-22 in Healthy Adult MalesCompletedNCT04203862Phase 1
- NPC-12G Gel 0.2% Sirolimus PK Bridging StudyCompletedNCT03972462Phase 1
- Long-term Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset SeizuresCompletedNCT01051193Phase 2/3
- A Randomized, Double-Blind, Placebo Controlled Study of NPC-02 in Patients With Zinc DeficiencyCompletedNCT02337569Phase 3
- Verification of the Efficacy of NPC-15 for Sleep Disorders of Children With Autism Spectrum DisordersCompletedNCT02757066Phase 2/3
- Dose Adjustment Study of NPC-02 in Patients With Zinc DeficiencyCompletedNCT02321865Phase 3
- Study of the Efficacy and Safety of NPC-15 for Sleep Disorders of Children With Neurodevelopmental DisordersCompletedNCT02757079Phase 3
- Efficacy and Safety, Long-Term Study of NPC-16 to Treat DysmenorrheaCompletedNCT02362711Phase 3
- Bioequivalence Study of NPC-12 (Sirolimus) Granules and TabletsCompletedNCT03765944Phase 1
- Long-term Trial of Topical Sirolimus to Angiofibroma in Patient With Tuberous Sclerosis ComplexCompletedNCT02634931Phase 3
- Investigation of Arrhythmogenic Effect of NPC-15 (NPC-15-7)CompletedNCT03475459Phase 1
- Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC)CompletedNCT02635789Phase 3
- Clinical Study of Caffeine for Apnea of PrematurityCompletedNCT01408173Phase 3
- Study of NPC-08 is to Treat for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma MultiformeCompletedNCT00919737Phase 1/2
- Study of NPC-07 for Fluorescence-guided Resection of Malignant GliomasCompletedNCT01167322Phase 3
- Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan.CompletedNCT00212368Phase 3
- Efficacy and Safety,Long-term Study of Low-dose Oral Contraceptive Pill to Treat Dysmenorrhea.CompletedNCT00212277Phase 3
- Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat DysmenorrheaCompletedNCT00212342Phase 3
- The Study of NPC-06 - Investigation of Safety, Efficacy and Pharmacokinetics of FosphenytoinCompletedNCT00908453Phase 3